AU2010320031B2 - (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine - Google Patents

(Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine Download PDF

Info

Publication number
AU2010320031B2
AU2010320031B2 AU2010320031A AU2010320031A AU2010320031B2 AU 2010320031 B2 AU2010320031 B2 AU 2010320031B2 AU 2010320031 A AU2010320031 A AU 2010320031A AU 2010320031 A AU2010320031 A AU 2010320031A AU 2010320031 B2 AU2010320031 B2 AU 2010320031B2
Authority
AU
Australia
Prior art keywords
pgp
immunogenic composition
group
antigen
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010320031A
Other languages
English (en)
Other versions
AU2010320031A1 (en
Inventor
Andrew Lees
James J. Mond
David Schwartz
Clifford M. Snapper
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Original Assignee
Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henry M Jackson Foundation for Advancedment of Military Medicine Inc filed Critical Henry M Jackson Foundation for Advancedment of Military Medicine Inc
Publication of AU2010320031A1 publication Critical patent/AU2010320031A1/en
Application granted granted Critical
Publication of AU2010320031B2 publication Critical patent/AU2010320031B2/en
Priority to AU2015238927A priority Critical patent/AU2015238927A1/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2010320031A 2009-11-16 2010-11-15 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine Ceased AU2010320031B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2015238927A AU2015238927A1 (en) 2009-11-16 2015-10-12 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26157209P 2009-11-16 2009-11-16
US61/261,572 2009-11-16
PCT/US2010/056742 WO2011060379A2 (en) 2009-11-16 2010-11-15 (poly)-glycerolphosphate-based anti-gram positive bacterial vaccine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2015238927A Division AU2015238927A1 (en) 2009-11-16 2015-10-12 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine

Publications (2)

Publication Number Publication Date
AU2010320031A1 AU2010320031A1 (en) 2012-06-14
AU2010320031B2 true AU2010320031B2 (en) 2015-07-16

Family

ID=43992459

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2010320031A Ceased AU2010320031B2 (en) 2009-11-16 2010-11-15 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine
AU2015238927A Abandoned AU2015238927A1 (en) 2009-11-16 2015-10-12 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2015238927A Abandoned AU2015238927A1 (en) 2009-11-16 2015-10-12 (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine

Country Status (6)

Country Link
US (1) US20130052204A1 (enExample)
EP (1) EP2501403A4 (enExample)
JP (1) JP6091214B2 (enExample)
AU (2) AU2010320031B2 (enExample)
CA (1) CA2781049A1 (enExample)
WO (1) WO2011060379A2 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3120140B1 (en) * 2014-03-21 2018-10-31 Biotage AB Method and apparatus for the equilibration of a packed chromatography column
US10781175B2 (en) 2016-07-15 2020-09-22 Am Chemicals Llc Solid supports and phosphoramidite building blocks for oligonucleotide conjugates
WO2025166099A1 (en) * 2024-02-02 2025-08-07 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Fire-retardant wood and wood composites, and compositions useful for making same

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072778A2 (en) * 2004-01-29 2005-08-11 Biosynexus, Inc. Use of amino-oxy functional groups in the preparation of vaccines conjugates
WO2008115254A1 (en) * 2006-07-20 2008-09-25 Nabi Biopharmaceuticals, Inc. Method of protecting against staphylococcal infection

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
GB9808932D0 (en) * 1998-04-27 1998-06-24 Chiron Spa Polyepitope carrier protein
GB9811347D0 (en) * 1998-05-28 1998-07-22 Oxoid Ltd Improvements in or relating diagnosis and treatment of bacterial infections
US6800728B2 (en) * 2000-03-22 2004-10-05 Solulink Biosciences, Inc. Hydrazine-based and carbonyl-based bifunctional crosslinking reagents
AU2004299501B2 (en) * 2003-12-17 2010-12-23 Wyeth Llc Immunogenic peptide carrier conjugates and methods of producing same
ES2730275T3 (es) * 2004-09-22 2019-11-11 Glaxosmithkline Biologicals Sa Composición inmunógena para uso en vacunación contra estafilococos

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005072778A2 (en) * 2004-01-29 2005-08-11 Biosynexus, Inc. Use of amino-oxy functional groups in the preparation of vaccines conjugates
WO2008115254A1 (en) * 2006-07-20 2008-09-25 Nabi Biopharmaceuticals, Inc. Method of protecting against staphylococcal infection

Also Published As

Publication number Publication date
EP2501403A4 (en) 2013-11-13
CA2781049A1 (en) 2011-05-19
JP2013510882A (ja) 2013-03-28
WO2011060379A2 (en) 2011-05-19
JP6091214B2 (ja) 2017-03-08
WO2011060379A3 (en) 2011-08-04
EP2501403A2 (en) 2012-09-26
AU2010320031A1 (en) 2012-06-14
US20130052204A1 (en) 2013-02-28
AU2015238927A1 (en) 2015-10-29

Similar Documents

Publication Publication Date Title
AU669354B2 (en) Synthetic haemophilus influenzae conjugate vaccine
JP5555623B2 (ja) コンジュゲートワクチン用修飾多糖
JP5759671B2 (ja) 結合方法
CA2660022C (en) Protein matrix vaccines and methods of making and administering such vaccines
RU2634405C2 (ru) Иммуногенная композиция
CA1340958C (en) Synthetic peptides representing a t-cell epitope as a carrier molecule for conjugate vaccines
JP6276227B2 (ja) Ｓｔａｐｈｙｌｏｃｏｃｃｕｓ．ａｕｒｅｕｓ５型および８型莢膜多糖の結合体
JP2013504588A (ja) 免疫原性の高いタンパク質マトリックスワクチン
JPH0832637B2 (ja) 合成免疫原
US20060228368A1 (en) Method of protecting against staphylococcal infection
AU2010320031B2 (en) (Poly)-glycerolphosphate-based anti-gram positive bacterial vaccine
CA2658508A1 (en) Method of protecting against staphylococcal infection
CN108367062B (zh) 抗金黄色葡萄球菌的免疫原性组合物
Santana et al. 12.9 Polysaccharide-Based Vaccines
HK1142261A (en) Modified polysaccharides for conjugate vaccines
HK1136220A (en) Protein matrix vaccines and methods of making and administering such vaccines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired